Y-mAbs Therapeutics
YMAB
#6603
Rank
โ‚น43.82 B
Marketcap
โ‚น978.54
Share price
-12.06%
Change (1 day)
141.02%
Change (1 year)

Y-mAbs Therapeutics (YMAB) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚น4.11 Billion

According to Y-mAbs Therapeutics 's latest financial reports the company's total liabilities are โ‚น4.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Y-mAbs Therapeutics - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น2.23 B-16.1%
2022-12-31โ‚น2.66 B9.67%
2021-12-31โ‚น2.43 B26.88%
2020-12-31โ‚น1.91 B53.93%
2019-12-31โ‚น1.24 B56.27%
2018-12-31โ‚น0.79 B25.12%
2017-12-31โ‚น0.63 B80.24%
2016-12-31โ‚น0.35 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น2.23 B-45.57%๐Ÿ‡บ๐Ÿ‡ธ USA